BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18799804)

  • 1. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of imatinib metabolites in rat and human liver microsomes: differentiation of hydroxylation from N-oxidation by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Ma S; Xu Y; Shou M
    Rapid Commun Mass Spectrom; 2009 May; 23(10):1446-50. PubMed ID: 19353558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry.
    Rochat B; Fayet A; Widmer N; Lahrichi SL; Pesse B; Décosterd LA; Biollaz J
    J Mass Spectrom; 2008 Jun; 43(6):736-52. PubMed ID: 18286663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of radicals formed in the reaction mixtures of rat liver microsomes with ADP, Fe3+ and NADPH using HPLC EPR and HPLC EPR MS.
    Minakata K; Okuno E; Nakamura M; Iwahashi H
    J Biochem; 2007 Jul; 142(1):73-8. PubMed ID: 17646184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the bioactivation of zomepirac and tolmetin by an oxidative pathway: identification of glutathione adducts in vitro in human liver microsomes and in vivo in rats.
    Chen Q; Doss GA; Tung EC; Liu W; Tang YS; Braun MP; Didolkar V; Strauss JR; Wang RW; Stearns RA; Evans DC; Baillie TA; Tang W
    Drug Metab Dispos; 2006 Jan; 34(1):145-51. PubMed ID: 16251255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural identification of imatinib cyanide adducts by mass spectrometry and elucidation of bioactivation pathway.
    Li AC; Yu E; Ring SC; Chovan JP
    Rapid Commun Mass Spectrom; 2014 Jan; 28(1):123-34. PubMed ID: 24285397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oxidative metabolism of hydralazine by rat liver microsomes.
    LaCagnin LB; Colby HD; O'Donnell JP
    Drug Metab Dispos; 1986; 14(5):549-54. PubMed ID: 2876860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active inhibitors of human leukocyte elastase. III. Identification and characterization of metabolites of L-694,458 by liquid chromatography-tandem mass spectrometry.
    Luffer-Atlas D; Vincent SH; Painter SK; Arison BH; Stearns RA; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):940-52. PubMed ID: 9280402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs.
    Lykkeberg AK; Cornett C; Halling-Sørensen B; Hansen SH
    J Pharm Biomed Anal; 2006 Sep; 42(2):223-31. PubMed ID: 16725295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes.
    Yenes S; Commandeur JN; Vermeulen NP; Messeguer A
    Chem Res Toxicol; 2004 Jul; 17(7):904-13. PubMed ID: 15257615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavin-containing monooxygenase-mediated metabolism of N-deacetyl ketoconazole by rat hepatic microsomes.
    Rodriguez RJ; Proteau PJ; Marquez BL; Hetherington CL; Buckholz CJ; O'Connell KL
    Drug Metab Dispos; 1999 Aug; 27(8):880-6. PubMed ID: 10421614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and disposition of imatinib mesylate in healthy volunteers.
    Gschwind HP; Pfaar U; Waldmeier F; Zollinger M; Sayer C; Zbinden P; Hayes M; Pokorny R; Seiberling M; Ben-Am M; Peng B; Gross G
    Drug Metab Dispos; 2005 Oct; 33(10):1503-12. PubMed ID: 16006570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced screening of glutathione-trapped reactive metabolites by in-source collision-induced dissociation and extraction of product ion using UHPLC-high resolution mass spectrometry.
    Zhu X; Kalyanaraman N; Subramanian R
    Anal Chem; 2011 Dec; 83(24):9516-23. PubMed ID: 22077671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.